Compare CXM & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CXM | ATEC |
|---|---|---|
| Founded | 2009 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2021 | 2006 |
| Metric | CXM | ATEC |
|---|---|---|
| Price | $5.63 | $7.77 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 11 |
| Target Price | $8.28 | ★ $22.00 |
| AVG Volume (30 Days) | 3.0M | ★ 4.5M |
| Earning Date | 06-03-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.04 |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $857,200,000.00 | $101,739,000.00 |
| Revenue This Year | $2.52 | $18.97 |
| Revenue Next Year | $4.94 | $16.70 |
| P/E Ratio | $59.72 | ★ N/A |
| Revenue Growth | ★ 7.64 | N/A |
| 52 Week Low | $4.72 | $6.82 |
| 52 Week High | $9.40 | $23.29 |
| Indicator | CXM | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 60.84 | 38.62 |
| Support Level | $5.19 | $6.82 |
| Resistance Level | $6.16 | $16.58 |
| Average True Range (ATR) | 0.22 | 0.39 |
| MACD | 0.06 | 0.11 |
| Stochastic Oscillator | 95.78 | 59.37 |
Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale, all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights, and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.